Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
about
Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophyOxidative stress and epigenetic regulation in ageing and age-related diseasesThe Role of ERK1/2 in the Development of Diabetic CardiomyopathyHeart failure: advanced development in genetics and epigeneticsEmerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series)Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK PathwayIn vivo imaging of histone deacetylases (HDACs) in the central nervous system and major peripheral organs.Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs.Protein expression, characterization and activity comparisons of wild type and mutant DUSP5 proteinsLactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes.Selective HDAC inhibition for the disruption of latent HIV-1 infection.Non-sirtuin histone deacetylases in the control of cardiac agingHistone Deacetylase 3 Is Required for Efficient T Cell Development.Dual Specificity Phosphatase 5 Is Essential for T Cell SurvivalHistone Modification of Nedd4 Ubiquitin Ligase Controls the Loss of AMPA Receptors and Cognitive Impairment Induced by Repeated Stress.DUSP8 Regulates Cardiac Ventricular Remodeling by Altering ERK1/2 Signaling.Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.Heart failure-specific changes in protein kinase signalling.Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.Epigenetic regulation and heart failure.Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation.Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs).Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs.DNA methylation regulated gene expression in organ fibrosis.DUSP5 functions as a feedback regulator of TNFα-induced ERK1/2 dephosphorylation and inflammatory gene expression in adipocytesClass I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes.Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart FailureThe Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart
P2860
Q26800200-207E5699-38E3-4C8B-8CBA-328433B20032Q26991587-4F9416D2-47BF-4FA7-BB99-6CBEA9C6F735Q28075539-95883BE4-D8EC-41DA-9D34-B78F4C205934Q28080771-8C24C942-972B-4665-A076-03D1480C8873Q28082797-BDEF0526-F6A3-4E76-8CAC-9AC6B57F7EF6Q28552721-D7836E99-D94B-4998-A52A-77402DC8C863Q30591009-DA39A297-FBEC-4CE0-B57B-69A6A30272E1Q33714350-E2CEBCF1-86C9-44B7-AFCE-0E1A6B2A42B8Q33998649-5D774C37-B772-4BD8-80C6-ED42D970F3DBQ34146683-6CEFC33C-5E71-4D01-8505-1673D911672CQ34985332-D8425A78-4921-48F6-842C-AF77799E7E3AQ35128221-13EC8F90-3419-46EF-B97F-833157BB16F0Q35227888-0B858DA4-632D-4DC5-9A76-3AF20464CBBAQ35695849-71C9EC65-3686-4F02-939B-A2FDFB5B9BECQ36174093-24DC1DBE-8927-441A-9C97-92A1BBAF453CQ36218156-E48E7D81-80CF-4CC0-9493-23F244D4F18FQ36587132-0E0432AE-B712-4BB5-B526-7482530111AEQ37079744-8115F097-AE98-46A4-8C33-2A124388CA05Q37139542-FE1CCF9B-70CA-4779-9C39-423A70AB115CQ38186583-DE1CE8E4-5AE7-40E0-B4F1-A7E71BFD3BBAQ38196176-16E322FC-A62E-46EE-9F9E-F4A95547CD9FQ38232304-EE77BBE3-E7E8-49B5-AC3F-7AA5968BFDACQ38662343-EF9EEE46-FBC0-4F9A-9202-2BE9BFE5E136Q38940877-68E7B6BB-0E48-4FD2-961C-210DA85F8473Q38965387-9C2A7F9F-19AD-446F-A577-D4A756A3E41EQ39304481-C842CE30-0E2E-4ED1-9A79-4C75D19F39E8Q42374205-D6C7B6A9-B339-4A29-96B9-AFF00C34FCAEQ47832574-6B18E023-D6AA-4E7B-BBCC-9515003EFCB3Q50630504-92B98D7E-70C5-4A2A-B6AD-E0D79EBD6172Q58766782-5D869707-56A0-4247-B755-C7C7AF72FC66Q60927794-08f1a379-4d81-e3e0-d0d4-2b6d6c907141
P2860
Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Signal-dependent repression of ...... and cardiomyocyte hypertrophy.
@en
type
label
Signal-dependent repression of ...... and cardiomyocyte hypertrophy.
@en
prefLabel
Signal-dependent repression of ...... and cardiomyocyte hypertrophy.
@en
P2093
P2860
P356
P1476
Signal-dependent repression of ...... and cardiomyocyte hypertrophy.
@en
P2093
Brian G Reid
Brooke C Harrison
Edward B Holson
Florence F Wagner
Mark Y Jeong
Michael F Wempe
Timothy A McKinsey
P2860
P304
P356
10.1073/PNAS.1301509110
P407
P577
2013-05-29T00:00:00Z